Literature DB >> 20360403

Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation.

Elizabeth F Redente1, David M Higgins, Lori D Dwyer-Nield, Ian M Orme, Mercedes Gonzalez-Juarrero, Alvin M Malkinson.   

Abstract

Alveolar macrophages and BDMCs undergo sequential biochemical changes during the chronic inflammatory response to chemically induced lung carcinogenesis in mice. Herein, we examine two chronic lung inflammation models-repeated exposure to BHT and infection with Mycobacterium tuberculosis-to establish whether similar macrophage phenotype changes occur in non-neoplastic pulmonary disease. Exposure to BHT or M. tuberculosis results in pulmonary inflammation characterized by an influx of macrophages, followed by systemic effects on the BM and other organs. In both models, pulmonary IFN-gamma and IL-4 production coincided with altered polarization of alveolar macrophages. Soon after BHT administration or M. tuberculosis infection, IFN-gamma content in BALF increased, and BAL macrophages became classically (M1) polarized, as characterized by increased expression of iNOS. As inflammation progressed in both models, the amount of BALF IFN-gamma content and BAL macrophage iNOS expression decreased, and BALF IL-4 content and macrophage arginase I expression rose, indicating alternative/M2 polarization. Macrophages present in M. tuberculosis-induced granulomas remained M1-polarized, implying that these two pulmonary macrophage populations, alveolar and granuloma-associated, are exposed to different activating cytokines. BDMCs from BHT-treated mice displayed polarization profiles similar to alveolar macrophages, but BDMCs in M. tuberculosis-infected mice did not become polarized. Thus, only alveolar macrophages in these two models of chronic lung disease exhibit a similar progression of polarization changes; polarization of BDMCs was specific to BHT-induced pulmonary inflammation, and polarization of granuloma macrophages was specific to the M. tuberculosis infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20360403      PMCID: PMC2892523          DOI: 10.1189/jlb.0609378

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  45 in total

Review 1.  Alternative versus classical activation of macrophages.

Authors:  S Goerdt; O Politz; K Schledzewski; R Birk; A Gratchev; P Guillot; N Hakiy; C D Klemke; E Dippel; V Kodelja; C E Orfanos
Journal:  Pathobiology       Date:  1999       Impact factor: 4.342

Review 2.  Chemokines and their receptors guiding T lymphocyte recruitment in lung inflammation.

Authors:  D D'Ambrosio; M Mariani; P Panina-Bordignon; F Sinigaglia
Journal:  Am J Respir Crit Care Med       Date:  2001-10-01       Impact factor: 21.405

Review 3.  Alternative activation of macrophages.

Authors:  Siamon Gordon
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

Review 4.  Microarray analysis of idiopathic pulmonary fibrosis.

Authors:  Naftali Kaminski
Journal:  Am J Respir Cell Mol Biol       Date:  2003-09       Impact factor: 6.914

Review 5.  Cytokine phenotypes serve as a paradigms for experimental immune-mediated lung diseases and remodeling.

Authors:  Steven L Kunkel; Stephen W Chensue; Nicholas Lukacs; Cory Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2003-09       Impact factor: 6.914

6.  Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice.

Authors:  J S Cox; B Chen; M McNeil; W R Jacobs
Journal:  Nature       Date:  1999-11-04       Impact factor: 49.962

7.  The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice.

Authors:  A K Bauer; L D Dwyer-Nield; J A Hankin; R C Murphy; A M Malkinson
Journal:  Toxicology       Date:  2001-12-01       Impact factor: 4.221

8.  Butylated hydroxytoluene (BHT) induction of pulmonary inflammation: a role in tumor promotion.

Authors:  A K Bauer; L D Dwyer-Nield; K Keil; K Koski; A M Malkinson
Journal:  Exp Lung Res       Date:  2001 Apr-May       Impact factor: 2.459

9.  M-1/M-2 macrophages and the Th1/Th2 paradigm.

Authors:  C D Mills; K Kincaid; J M Alt; M J Heilman; A M Hill
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

10.  A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung.

Authors:  C D D'Souza; A M Cooper; A A Frank; S Ehlers; J Turner; A Bendelac; I M Orme
Journal:  Am J Respir Cell Mol Biol       Date:  2000-08       Impact factor: 6.914

View more
  60 in total

1.  Pulmonary macrophage subpopulations in the induction and resolution of acute lung injury.

Authors:  Laura K Johnston; Cliff R Rims; Sean E Gill; John K McGuire; Anne M Manicone
Journal:  Am J Respir Cell Mol Biol       Date:  2012-06-21       Impact factor: 6.914

2.  Neutrophils are required for 3-methylcholanthrene-initiated, butylated hydroxytoluene-promoted lung carcinogenesis.

Authors:  Haris G Vikis; Andrew E Gelman; Andrew Franklin; Lauren Stein; Amy Rymaszewski; Jihong Zhu; Pengyuan Liu; Jay W Tichelaar; Alexander S Krupnick; Ming You
Journal:  Mol Carcinog       Date:  2011-10-17       Impact factor: 4.784

3.  Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection.

Authors:  Emanuela Greco; Gianluca Quintiliani; Marilina B Santucci; Annalucia Serafino; Anna Rita Ciccaglione; Cinzia Marcantonio; Massimiliano Papi; Giuseppe Maulucci; Giovanni Delogu; Angelo Martino; Delia Goletti; Loredana Sarmati; Massimo Andreoni; Alfonso Altieri; Mario Alma; Nadia Caccamo; Diana Di Liberto; Marco De Spirito; Nigel D Savage; Roberto Nisini; Francesco Dieli; Tom H Ottenhoff; Maurizio Fraziano
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-25       Impact factor: 11.205

4.  Inflammatory cytokine and chemokine expression in sympathetic ophthalmia: a pilot study.

Authors:  Emiko Furusato; DeFen Shen; Xiaoguang Cao; Bungo Furusato; Robert B Nussenblatt; Elisabeth J Rushing; Chi-Chao Chan
Journal:  Histol Histopathol       Date:  2011-09       Impact factor: 2.303

5.  Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury.

Authors:  Jiping Zhao; Hao Yu; Yudong Liu; Sara A Gibson; Zhaoqi Yan; Xin Xu; Amit Gaggar; Pui-Kai Li; Chenglong Li; Shi Wei; Etty N Benveniste; Hongwei Qin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-16       Impact factor: 5.464

6.  Single cell RNA sequencing identifies unique inflammatory airspace macrophage subsets.

Authors:  Kara J Mould; Nathan D Jackson; Peter M Henson; Max Seibold; William J Janssen
Journal:  JCI Insight       Date:  2019-03-07

7.  Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.

Authors:  Elizabeth F Redente; Rebecca C Keith; William Janssen; Peter M Henson; Luis A Ortiz; Gregory P Downey; Donna L Bratton; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

8.  Myeloid-specific Fos-related antigen-1 regulates cigarette smoke-induced lung inflammation, not emphysema, in mice.

Authors:  Michelle Vaz; Subbiah Rajasekaran; Haranatha R Potteti; Sekhar P Reddy
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

9.  A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT.

Authors:  Andrew V Kossenkov; Rehman Qureshi; Noor B Dawany; Jayamanna Wickramasinghe; Qin Liu; R Sonali Majumdar; Celia Chang; Sandy Widura; Trisha Kumar; Wen-Hwai Horng; Eric Konnisto; Gerard Criner; Jun-Chieh J Tsay; Harvey Pass; Sai Yendamuri; Anil Vachani; Thomas Bauer; Brian Nam; William N Rom; Michael K Showe; Louise C Showe
Journal:  Cancer Res       Date:  2018-11-28       Impact factor: 12.701

10.  Enhanced M1 macrophage polarization in human helicobacter pylori-associated atrophic gastritis and in vaccinated mice.

Authors:  Marianne Quiding-Järbrink; Sukanya Raghavan; Malin Sundquist
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.